Ha habido 50 transacciones internas recientes registradas para Protara Therapeutics, Inc. (TARA), incluyendo 21 compras y 20 ventas. El total de compras internas fue valorado en $5.07M y el total de ventas internas en $688.38K.
Internos destacados con actividad reciente incluyen Zummo Jacqueline, Fabbio Patrick, Shefferman Jesse. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TARA
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Zummo Jacqueline |
Chief R&d Officer |
Venta Informativa |
22,598 |
$5.26 |
$118.87K |
95,961 |
| 2026-01-26 |
Fabbio Patrick |
Chief Financial Officer |
Retención Fiscal de RSU |
3,261 |
$6.67 |
$21.75K |
64,115 |
| 2026-01-26 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Retención Fiscal de RSU |
3,724 |
$6.67 |
$24.84K |
118,559 |
| 2026-01-26 |
Shefferman Jesse |
CEO and President |
Retención Fiscal de RSU |
8,732 |
$6.67 |
$58.24K |
1,021,832 |
| 2026-01-26 |
Fry Hannah |
VP, Controller |
Retención Fiscal de RSU |
1,457 |
$6.67 |
$9.72K |
42,723 |
| 2026-01-20 |
Fabbio Patrick |
Chief Financial Officer |
Retención Fiscal de RSU |
3,063 |
$5.60 |
$17.15K |
67,376 |
| 2026-01-20 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Retención Fiscal de RSU |
6,578 |
$5.60 |
$36.84K |
122,283 |
| 2026-01-20 |
Shefferman Jesse |
CEO and President |
Retención Fiscal de RSU |
16,322 |
$5.60 |
$91.4K |
1,030,564 |
| 2026-01-20 |
Fry Hannah |
VP, Controller |
Retención Fiscal de RSU |
2,132 |
$5.60 |
$11.94K |
44,180 |
| 2026-01-16 |
Fabbio Patrick |
Chief Financial Officer |
Concesión de RSU |
28,000 |
- |
- |
70,439 |
| 2026-01-16 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Concesión de RSU |
30,000 |
- |
- |
128,861 |
| 2026-01-16 |
Shefferman Jesse |
CEO and President |
Concesión de RSU |
524,000 |
$5.01 |
$2.63M |
524,000 |
| 2026-01-16 |
Conkling William |
Chief Commercial Officer |
Concesión de RSU |
26,000 |
- |
- |
76,000 |
| 2026-01-16 |
Fry Hannah |
VP, Controller |
Concesión de RSU |
9,500 |
- |
- |
46,312 |
| 2026-01-16 |
Nicacio Leonardo Viana |
Chief Medical Officer |
Concesión de RSU |
26,000 |
- |
- |
78,181 |
| 2025-06-27 |
Shefferman Jesse |
CEO and President |
Donación (Otorgada) |
3,367 |
- |
- |
959,886 |
| 2025-06-26 |
Shefferman Jesse |
CEO and President |
Donación (Otorgada) |
3,400 |
- |
- |
973,453 |
| 2025-06-24 |
Shefferman Jesse |
CEO and President |
Donación (Otorgada) |
300,000 |
- |
- |
659,886 |
| 2025-06-12 |
Beshar Luke M |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Sargen Gregory |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Garceau Roger |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Levy Richard S |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Smith Cynthia |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Flannelly Barry P |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Huang Jane |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-12 |
Solomon Michael Edward |
Director |
Concesión de RSU |
24,000 |
$3.26 |
$78.24K |
24,000 |
| 2025-06-02 |
Conkling William |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-02 |
Conkling William |
Chief Commercial Officer |
Concesión de RSU |
50,000 |
- |
- |
50,000 |
| 2025-05-14 |
Levy Richard S |
Director |
Compra Informativa |
20,000 |
$3.19 |
$63.8K |
51,000 |
| 2025-04-15 |
Nicacio Leonardo Viana |
Chief Medical Officer |
Desconocido |
- |
- |
- |
2,181 |
| 2025-04-15 |
Nicacio Leonardo Viana |
Chief Medical Officer |
Concesión de RSU |
50,000 |
- |
- |
52,181 |
| 2025-03-26 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Venta Informativa |
21,224 |
$4.53 |
$96.14K |
98,861 |
| 2025-01-24 |
Fabbio Patrick |
Chief Financial Officer |
Concesión de RSU |
23,500 |
- |
- |
45,500 |
| 2025-01-24 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Concesión de RSU |
24,500 |
- |
- |
126,639 |
| 2025-01-24 |
Shefferman Jesse |
CEO and President |
Concesión de RSU |
387,000 |
$4.53 |
$1.75M |
387,000 |
| 2025-01-24 |
Fry Hannah |
VP, Controller |
Concesión de RSU |
9,500 |
- |
- |
38,942 |
| 2025-01-24 |
Fabbio Patrick |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-01-24 |
Zummo Jacqueline |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-01-24 |
Shefferman Jesse |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-01-24 |
Fry Hannah |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-01-21 |
Fabbio Patrick |
Chief Financial Officer |
Retención Fiscal de RSU |
3,061 |
$4.76 |
$14.57K |
18,939 |
| 2025-01-21 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Retención Fiscal de RSU |
6,554 |
$4.76 |
$31.2K |
95,585 |
| 2025-01-21 |
Shefferman Jesse |
CEO and President |
Retención Fiscal de RSU |
15,469 |
$4.76 |
$73.63K |
913,553 |
| 2025-01-21 |
Fry Hannah |
VP, Controller |
Retención Fiscal de RSU |
2,130 |
$4.76 |
$10.14K |
27,312 |
| 2025-01-03 |
Zummo Jacqueline |
Chf Scientific Operations Off |
Retención Fiscal de RSU |
2,157 |
$6.14 |
$13.24K |
102,139 |
| 2025-01-03 |
Shefferman Jesse |
CEO and President |
Retención Fiscal de RSU |
6,479 |
$6.14 |
$39.78K |
929,022 |
| 2025-01-03 |
Fry Hannah |
VP, Controller |
Retención Fiscal de RSU |
394 |
$6.14 |
$2.42K |
29,442 |
| 2024-09-12 |
Opaleye Management Inc. |
10 Percent Owner |
Venta Informativa |
6,500 |
$1.71 |
$11.11K |
45,000 |
| 2024-09-11 |
Opaleye Management Inc. |
10 Percent Owner |
Venta Informativa |
1,600 |
$1.71 |
$2.74K |
51,500 |
| 2024-09-10 |
Opaleye Management Inc. |
10 Percent Owner |
Venta Informativa |
1,500 |
$1.77 |
$2.65K |
53,100 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
